Alector (ALEC) Other financing activities (2018 - 2026)

Alector (ALEC) posted quarterly Other financing activities of $25000.0 for Q1 2026, down 73.68% quarter-over-quarter from $95000.0 in Q4 2025.

Alector (ALEC) Other financing activities (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Other financing activities for 9 consecutive years, with $25000.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Other financing activities changed N/A year-over-year to $25000.0; the TTM figure through Mar 2026 stood at $242000.0 (changed N/A YoY), while the FY2025 annual figure was $217000.0, changed N/A from the prior year.
Other financing activities retreated to $25000.0 in Q1 2026 per ALEC's latest filing, from $95000.0 in the prior quarter.
Across five years, Other financing activities topped out at $2.5 million in Q1 2022 and bottomed at -$1.6 million in Q2 2022.
Historically, Other financing activities has averaged $397666.7 across 5 years, with a median of $108500.0 in 2025.
Annual changes were most pronounced in 2023 — Other financing activities soared 1182.61% — and 2024, when it sank 209.15%.
Alector's Other financing activities stood at $46000.0 in 2022, then jumped by 1182.61% to $590000.0 in 2023, then tumbled by 209.15% to -$644000.0 in 2024, then jumped by 114.75% to $95000.0 in 2025, then tumbled by 73.68% to $25000.0 in 2026.
Business Quant data shows ALEC's Other financing activities at $25000.0 in Q1 2026, $95000.0 in Q4 2025, and $122000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Alector	218.85 Mn	46.05 Mn	-

Download Data